Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

Overview of attention for article published in Cancer Medicine, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 129 Dimensions

Readers on

mendeley: 103 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 19,781 followers.

The benefit of multi‐gene testing for risk assessment in BC/OC families: results of the German Consortium for Hereditary Breast and Ovarian Cancer https://t.co/a9BNmiexrH https://t.co/dZFXfTL4Ie

27 Jun 2020

Reply Repost Favourite

https://t.co/hcg23YPNgA

27 Mar 2018

Reply Repost Favourite

RT @varsome: #Gene panel testing of 5589 BRCA1/2-negative index German patients with #breastcancer identified multiple class 5 https://t.c…

27 Mar 2018

Reply Repost Favourite

#Gene panel testing of 5589 BRCA1/2-negative index German patients with #breastcancer identified multiple class 5 https://t.co/nB1gCdP5Nk and class 4 variants #oncology #genetics #BeatCancer https://t.co/6xjuke8ymb

23 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.